{"id":68790,"date":"2026-02-22T07:34:38","date_gmt":"2026-02-22T07:34:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68790"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"bpc-157-tb-500-blend","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-br\/product\/bpc-157-tb-500-blend\/","title":{"rendered":"Mistura BPC-157 + TB-500"},"content":{"rendered":"<p><!-- medsbase-related-alts-v1 --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 16px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 style=\"margin-top: 0; font-size: 17px;\">Resposta R\u00e1pida \u2014 O que \u00e9 a Mistura BPC-157 + TB-500?<\/h3>\n<p style=\"margin: 0;\">This is a pre-mixed peptide supplied as a 50\/50 blend of BPC-157 and TB-500 (Thymosin Beta-4) in a single lyophilized vial. Three total-mg strengths are available: <strong>10 mg<\/strong> (5 mg de BPC + 5 mg de TB), <strong>20 mg<\/strong> (10 mg + 10 mg), e <strong>30 mg<\/strong> (15 mg + 15 mg) \u2014 each in pack sizes of 10, 20, or 30 vials. The pre-blend saves a reconstitution step for protocols that study these two compounds together.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que voc\u00ea obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-br\/reviews\/\">\ud83d\udce6 Cada pedido \u00e9 coberto pela nossa<\/a><\/div>\n<h2>BPC-157 + TB-500 Blend \u2014 Pre-Mixed Dual-Peptide Compound<\/h2>\n<p>BPC-157 and TB-500 are the two most-studied peptides in the tissue-repair and systemic-recovery space. They target complementary pathways: BPC-157 (Body Protection Compound, a 15-amino-acid fragment derived from a gastric protein) is investigated for localized tissue repair, angiogenesis, and modulation of growth factors, while TB-500 (a synthetic fragment of Thymosin Beta-4) is studied for systemic cell migration, G-actin sequestration, and broader recovery signaling. Study protocols that investigate the two compounds together typically dose them in a 1:1 ratio, which is why a pre-mixed 50\/50 blend has become a standard supply format. This product eliminates the extra reconstitution step that would otherwise be required when running a combined-dosing study. <\/p>\n<h2>Por que uma Mistura em vez de Dois Frascos Separados?<\/h2>\n<p>Study labs running combined BPC-157 + TB-500 protocols have two supply choices: (a) order the peptides separately and reconstitute each vial independently, mixing the final doses at injection time, or (b) order a pre-blended vial and reconstitute once. Both approaches are valid. The blend is chosen most often when:<\/p>\n<ul>\n<li>The protocol is fixed at a 1:1 BPC:TB ratio across all study arms.<\/li>\n<li>Tempo de reconstitui\u00e7\u00e3o, carga de t\u00e9cnica est\u00e9ril e estoque de frascos s\u00e3o centros de custo significativos.<\/li>\n<li>\u00c9 desejada uma propor\u00e7\u00e3o consistente de lote para lote (uma pr\u00e9-mistura \u00e9 fabricada para uma \u00fanica especifica\u00e7\u00e3o; frascos encomendados separadamente podem vir de lotes de produ\u00e7\u00e3o diferentes).<\/li>\n<\/ul>\n<p>Os compostos individuais permanecem dispon\u00edveis para protocolos que necessitam de titula\u00e7\u00e3o de dose independente de BPC-157 vs TB-500. Para informa\u00e7\u00f5es sobre os pept\u00eddeos individuais, consulte nosso <a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a> e <a href=\"https:\/\/medsbase.com\/pt-br\/tb-500-thymosin-beta-4-peptide-guide\/\">Guia de TB-500 (Thymosin Beta-4)<\/a>. Para uma compara\u00e7\u00e3o direta entre tratamentos, consulte o <a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157-vs-tb-500-comparison-guide\/\">Comparativo BPC-157 vs TB-500<\/a>. <\/p>\n<h2>Op\u00e7\u00f5es de Concentra\u00e7\u00e3o \u2014 Como Escolher<\/h2>\n<p>All three strengths contain the same 1:1 BPC-157: TB-500 ratio. The total-mg figure refers to the combined peptide mass per vial:<\/p>\n<ul>\n<li><strong>10 mg no total<\/strong> \u2014 5 mg BPC-157 + 5 mg TB-500 per vial. Suited to protocols studying lower dose ranges or short study durations. Best cost per vial; highest per-mg cost.<\/li>\n<li><strong>20 mg no total<\/strong> \u2014 10 mg BPC-157 + 10 mg TB-500 per vial. The most commonly ordered strength for multi-week protocols. Balanced on cost-per-mg and practical working-dilution volumes.<\/li>\n<li><strong>30 mg no total<\/strong> \u2014 15 mg BPC-157 + 15 mg TB-500 per vial. Best cost per mg; suited to longer studies or higher-dose arms.<\/li>\n<\/ul>\n<p>Embalagens com 10, 20 ou 30 frascos est\u00e3o dispon\u00edveis com pre\u00e7os escalonados \u2014 os pacotes de 20 e 30 frascos oferecem economia significativa por frasco em compara\u00e7\u00e3o com o tamanho inicial de 10 frascos. <\/p>\n<h2>Reconstitution \u2014 Standard Protocol<\/h2>\n<p>A mistura \u00e9 fornecida liofilizada. O m\u00e9todo de dilui\u00e7\u00e3o para trabalho \u00e9 o mesmo que para frascos de pept\u00eddeo \u00fanico:<\/p>\n<ol>\n<li>Reconstitua com \u00e1gua bacteriost\u00e1tica. Uma dilui\u00e7\u00e3o de trabalho comum para o frasco de 20 mg \u00e9 de 2 mL de <a href=\"https:\/\/medsbase.com\/pt-br\/bac-water\/\">\u00c1gua BAC<\/a>, resultando em 10 mg\/mL de pept\u00eddeo total (5 mg\/mL de BPC + 5 mg\/mL de TB).<\/li>\n<li>Adicione a \u00e1gua bacteriost\u00e1tica gentilmente pela parede interna do frasco \u2014 n\u00e3o jogue diretamente sobre o p\u00f3 liofilizado.<\/li>\n<li>Agite suavemente por 30\u201360 segundos at\u00e9 dissolver completamente. N\u00e3o agite vigorosamente; a agita\u00e7\u00e3o na interface ar-\u00e1gua pode fragmentar as estruturas pept\u00eddicas.<\/li>\n<li>Identifique o frasco com a data de reconstitui\u00e7\u00e3o. Mantenha refrigerado a 2\u20138 \u00b0C e use dentro de 30 dias.<\/li>\n<\/ol>\n<p>Para um tratamento detalhado da matem\u00e1tica de dilui\u00e7\u00e3o e erros comuns de reconstitui\u00e7\u00e3o, consulte nosso <a href=\"https:\/\/medsbase.com\/pt-br\/bac-water-reconstitution-guide\/\">guia de reconstitui\u00e7\u00e3o com \u00e1gua bacteriost\u00e1tica<\/a>. <\/p>\n<h2>Context \u2014 Combined BPC + TB Dosing<\/h2>\n<p>The rationale for studying BPC-157 and TB-500 together rests on their non-overlapping mechanisms. BPC-157 studies focuses on localized repair \u2014 angiogenesis, growth-factor modulation (FGF, VEGF, EGF), and tendon-to-bone attachment signaling. TB-500 studies targets systemic cell migration, G-actin binding, and broader inflammation-resolution pathways. In combination protocols, investigators hypothesize additive or even synergistic effects across the overlap zone between localized and systemic recovery. Typical reported protocol dose ranges (per peptide component):<\/p>\n<ul>\n<li>Componente BPC-157: 250\u2013500 \u00b5g por dose, uma ou duas vezes ao dia, em ciclos de 4\u20138 semanas.<\/li>\n<li>Componente TB-500: 2\u20135 mg por semana, geralmente divididos em 2\u20133 doses por semana.<\/li>\n<\/ul>\n<p>These figures reflect published studies protocols and are not prescribing recommendations. Neither BPC-157 nor TB-500 is approved for human therapeutic use by the FDA, EMA, MHRA, or TGA. Both are supplied as compounds for clinical investigation only. <\/p>\n<h2>Armazenamento &amp; Manuseio<\/h2>\n<ul>\n<li>Armazene frascos liofilizados a 2\u20138 \u00b0C (geladeira). Tr\u00e2nsito breve em temperatura ambiente \u00e9 tolerado.<\/li>\n<li>Ap\u00f3s a reconstitui\u00e7\u00e3o, mantenha a solu\u00e7\u00e3o refrigerada e use dentro de 30 dias.<\/li>\n<li>Evite ciclos repetidos de congelamento e descongelamento.<\/li>\n<li>Proteja da luz direta. Frascos \u00e2mbar ou embalagem com papel alum\u00ednio s\u00e3o prefer\u00edveis para armazenamento refrigerado prolongado.<\/li>\n<li>Use \u00e1lcool isoprop\u00edlico 70% para limpar o tamp\u00e3o de borracha antes de cada pun\u00e7\u00e3o com agulha.<\/li>\n<\/ul>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Todo pedido \u00e9 coberto pelo nosso <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Reenvio Garantido<\/strong><\/a> \u2014 se sua encomenda n\u00e3o chegar em 20 dias \u00fateis, n\u00f3s a reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">composto (BPC-157 137525-51-0 \/ TB-500 77591-33-4)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157: C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub> \u00b7 TB-500: C<sub>212<\/sub>H<sub>350<\/sub>N<sub>56<\/sub>O<sub>78<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157: 1419,55 Da \u00b7 TB-500: ~4963 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157 (15 aa) + Timosina \u03b2-4 acetilada (43 aa) coliofilizadas em um \u00fanico frasco<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (ou conforme fornecido)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA sob solicita\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Mistura liofilizada: 2\u20138 \u00b0C (geladeira) para estoque de trabalho; \u221220 \u00b0C para armazenamento de longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, usar em at\u00e9 ~30 dias. Evitar agita\u00e7\u00e3o vigorosa. N\u00e3o congelar e descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de uso mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Related Compounds<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a> \u2014 o composto individual.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/tb-500-thymosin-beta-4-peptide-guide\/\">Guia de TB-500 (Thymosin Beta-4)<\/a> \u2014 o composto individual.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157-vs-tb-500-comparison-guide\/\">Comparativo BPC-157 vs TB-500<\/a> \u2014 tratamento direto frente a frente dos dois pept\u00eddeos.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/ghk-cu-copper-peptide-anti-aging-guide\/\">GHK-Cu (Copper Peptide) guide<\/a> \u2014 o composto de recupera\u00e7\u00e3o mais frequentemente combinado com protocolos BPC\/TB.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/best-peptides-for-muscle-recovery\/\">Melhores pept\u00eddeos para stack de recupera\u00e7\u00e3o muscular<\/a> \u2014 artigo de cluster-hub abordando protocolos combinados.<\/li>\n<\/ul>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is the BPC-157: TB-500 ratio in the blend?<\/h3>\n<p>Todas as tr\u00eas concentra\u00e7\u00f5es s\u00e3o fornecidas em uma propor\u00e7\u00e3o fixa de 1:1 por massa. O frasco de 10 mg cont\u00e9m 5 mg de BPC-157 + 5 mg de TB-500; o frasco de 20 mg cont\u00e9m 10 mg + 10 mg; o frasco de 30 mg cont\u00e9m 15 mg + 15 mg. <\/p>\n<h3>Por que escolher a mistura em vez de dois frascos separados?<\/h3>\n<p>A mistura economiza uma etapa de reconstitui\u00e7\u00e3o e garante uma propor\u00e7\u00e3o consistente de 1:1 ao longo do estudo. Frascos pedidos separadamente oferecem mais flexibilidade se voc\u00ea deseja ajustar a dosagem dos dois compostos de forma independente. <\/p>\n<h3>Qual concentra\u00e7\u00e3o devo pedir?<\/h3>\n<p>The 20 mg vial is the most commonly ordered strength for typical protocols. The 10 mg strength suits short studies or lower-dose arms. The 30 mg strength offers the best per-mg cost for longer studies or higher-dose arms. <\/p>\n<h3>Como a mistura deve ser reconstitu\u00edda?<\/h3>\n<p>Use \u00e1gua bacteriost\u00e1tica. Para o frasco de 20 mg, 2 mL de BAC Water fornecem uma concentra\u00e7\u00e3o de trabalho de 10 mg\/mL de pept\u00eddeo total. Adicione a \u00e1gua gentilmente pela lateral do frasco e gire \u2014 n\u00e3o agite. <\/p>\n<h3>Quanto tempo dura a mistura reconstitu\u00edda?<\/h3>\n<p>Refrigerada a 2\u20138 \u00b0C, use dentro de 30 dias. Evite ciclos repetidos de congelamento e descongelamento. Descarte se a solu\u00e7\u00e3o ficar turva ou mudar de cor. <\/p>\n<h3>What are the typical doses for this blend?<\/h3>\n<p>Published studies protocols typically dose 250\u2013500 \u00b5g of the BPC-157 component once or twice daily, and 2\u20135 mg of the TB-500 component weekly split across 2\u20133 doses. Because the ratio is fixed at 1:1, drawing a volume that delivers the target BPC-157 dose will simultaneously deliver the same mass of TB-500. <\/p>\n<h3>Esta mistura \u00e9 aprovada pela FDA?<\/h3>\n<p>No. Neither BPC-157 nor TB-500 is approved by the FDA, EMA, MHRA, TGA, or any other regulatory authority for human therapeutic use. This product is supplied strictly as a compound for clinical investigation. <\/p>\n<h3>A mistura pode ser armazenada em temperatura ambiente?<\/h3>\n<p>Os frascos liofilizados n\u00e3o reconstitu\u00eddos s\u00e3o est\u00e1veis durante o transporte breve em temperatura ambiente, mas devem ser refrigerados ap\u00f3s a chegada. Uma vez reconstitu\u00edda, a solu\u00e7\u00e3o deve ser refrigerada. <\/p>\n<h3>O pacote de 20 mg dura mais do que dois pacotes de 10 mg?<\/h3>\n<p>Por frasco, sim \u2014 o frasco de 20 mg cont\u00e9m o dobro de pept\u00eddeo por frasco. Em n\u00edvel de kit, um pacote de 10 frascos com concentra\u00e7\u00e3o de 20 mg cont\u00e9m a mesma quantidade total de pept\u00eddeo (200 mg) que dois pacotes de 10 frascos com concentra\u00e7\u00e3o de 10 mg (tamb\u00e9m 200 mg), mas com um custo menor por mg. <\/p>\n<h3>Qual \u00e9 a vida \u00fatil do frasco fechado?<\/h3>\n<p>Pept\u00eddeos liofilizados armazenados corretamente a 2\u20138 \u00b0C permanecem est\u00e1veis at\u00e9 a data de validade indicada pelo fabricante \u2014 normalmente 18\u201324 meses a partir da produ\u00e7\u00e3o. Sempre verifique a data de validade no frasco individual. <\/p>\n<h3>Como a mistura se compara \u00e0 compra de BPC-157 e TB-500 separadamente?<\/h3>\n<p>Funcionalmente equivalente se o seu protocolo for executado em uma propor\u00e7\u00e3o de 1:1. A mistura economiza uma etapa de reconstitui\u00e7\u00e3o por lote e garante consist\u00eancia na propor\u00e7\u00e3o. A abordagem com frascos separados \u00e9 prefer\u00edvel se voc\u00ea quiser variar as doses dos dois pept\u00eddeos independentemente entre os grupos de estudo. <\/p>\n<h3>Voc\u00eas enviam esta combina\u00e7\u00e3o internacionalmente?<\/h3>\n<p>Sim. Todos os pedidos contendo apenas pept\u00eddeos s\u00e3o enviados mundialmente atrav\u00e9s do nosso transportador dedicado para pept\u00eddeos sem custo adicional. Pedidos mistos (pept\u00eddeos mais outros medicamentos) utilizam nosso servi\u00e7o padr\u00e3o de envio internacional rastreado. <\/p>\n<h3>What is the recommended protocol for the BPC-157 + TB-500 blend?<\/h3>\n<p>Published preclinical studies using BPC-157 and TB-500 together employs each peptide at its individual protocol parameters \u2014 BPC-157 in the 250\u2013500 mcg range and TB-500 in the 2\u20135 mg range, with BPC-157 dosed more frequently due to its shorter half-life. Specific dosing for any application should be derived from peer-reviewed literature relevant to the study model. <\/p>\n<h3>Why does combining BPC-157 and TB-500 interest users?<\/h3>\n<p>BPC-157 and TB-500 target complementary tissue-repair pathways \u2014 BPC-157 primarily via VEGF, nitric oxide, and growth-hormone-receptor signalling with strong localised effects; TB-500 via actin binding, angiogenesis, and systemic distribution. Preclinical combination models have used both peptides together, and the two are frequently studied in the same repair and recovery contexts. <\/p>\n<h3>Qual padr\u00e3o de pureza a MedsBase fornece para esta combina\u00e7\u00e3o?<\/h3>\n<p>Todos os frascos desta combina\u00e7\u00e3o estocados pela MedsBase s\u00e3o fornecidos com pureza HPLC de 99%+ em forma liofilizada. Um certificado de an\u00e1lise (COA) est\u00e1 dispon\u00edvel mediante solicita\u00e7\u00e3o \u2014 entre em contato com nossa equipe de suporte ap\u00f3s realizar seu pedido e encaminharemos o COA espec\u00edfico do lote para os frascos que voc\u00ea recebeu. <!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leia nosso guia completo baseado em evid\u00eancias: <a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157-vs-tb-500-comparison-guide\/\"><strong>BPC-157 vs TB-500 \u2014 compara\u00e7\u00e3o direta e orienta\u00e7\u00e3o de protocolo combinado<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- medsbase-peptide-cluster-footer --><\/p>\n<div style=\"background: #eef7ee; border-left: 4px solid #4caf50; padding: 16px 22px; margin: 24px 0; border-radius: 4px;\">\n<h3 style=\"margin-top: 0; font-size: 16px;\">Related Peptide Guides<\/h3>\n<ul style=\"margin: 8px 0 0 0;\">\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 Guide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500 (Thymosin Beta-4) Guide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500 \u2014 Compara\u00e7\u00e3o Direta<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/best-peptides-for-muscle-recovery\/\">Melhores Pept\u00eddeos para Recupera\u00e7\u00e3o Muscular \u2014 Guia de Stack<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\">All Peptides at MedsBase<\/a><\/li>\n<\/ul>\n<\/div>\n<p><!-- \/medsbase-peptide-cluster-footer --><br \/>\n<!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Suporta sinaliza\u00e7\u00e3o celular<br \/>\n\u2705 Promove modelagem tecidual<br \/>\n\u2705 Enhances angiogenic activity<br data-is-only-node=\"\" \/>\u2705 Atividade fibrobl\u00e1stica observada<br \/>\n\u2705 Est\u00e1vel em ensaios experimentais<\/p>\n<p><strong>BPC-157 + TB-500<\/strong> cont\u00e9m composto de pept\u00eddeo sint\u00e9tico.<\/p>","protected":false},"featured_media":70988,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5448,5441,5442],"class_list":["post-68790","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-bpc-157","product_tag-bpc-157-tb-500-blend","product_tag-peptide","product_tag-tb-500","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product\/68790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/comments?post=68790"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media\/70988"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media?parent=68790"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_brand?post=68790"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_cat?post=68790"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_tag?post=68790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}